CD44 and central nervous system cancer: In glioma cells, lactate-stimulated malignant glioma exosomes enhance the migratory and angiogenic effects of tumor cells through CD44, and there is a positive correlation between the malignant behavior of gliomas and their exosomal CD44 levels [16].